- Filed
- Feb 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 11, 2026 | 1.32M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 823.13K sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 478.31K sh |
| Shares Diluted restated | Q3 2026 · Dec 31, 2024 | 174.53K sh |
| Shares Diluted restated | Q3 2026 · Dec 31, 2024 | 147.52K sh |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$5.25M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | −$5.97M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $6.96M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $5.5M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $4.83M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $6.71M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $5.75M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $3.42M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $5.12M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $4.33M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $6.02M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $8.71M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | $5.77M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $1.26M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $1.9M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $1.34M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $2.24M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $7.14M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $5.95M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $8.06M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $7.36M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$2.45 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$11.01 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$10.05 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$48.35 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$2.45 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$11.01 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$10.05 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$48.35 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $741.65K |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $2M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $816.38K |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $2.53M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $532.78K |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $1.32M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $240.2K |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $883.62K |
| Net Income | Q3 2026 · Dec 31, 2025 | −$2.02M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$5.27M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$1.49M |
| Net Income | Q3 2026 · Jun 30, 2025 | −$1.76M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$1.75M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$7.13M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$2.81M |
| Net Income | Q3 2026 · Jun 30, 2024 | −$2.57M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$2.06M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$5.36M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$1.81M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$7.34M |